{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:03:40Z","timestamp":1792202620768,"version":"4.4.0"},"reference-count":169,"publisher":"Elsevier","isbn-type":[{"value":"9780128151273","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001384","name":"Samuel Waxman Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA058236"],"award-info":[{"award-number":["P50 CA058236"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA108520"],"award-info":[{"award-number":["R01 CA108520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA16059"],"award-info":[{"award-number":["P30 CA16059"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA097318"],"award-info":[{"award-number":["R01 CA097318"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA104177"],"award-info":[{"award-number":["P01 CA104177"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-14-1-0409"],"award-info":[{"award-number":["W81XWH-14-1-0409"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001767","name":"National Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.acr.2018.02.005","type":"book-chapter","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T11:57:58Z","timestamp":1519991878000},"page":"143-182","source":"Crossref","is-referenced-by-count":52,"title":["Role of MDA-7\/IL-24 a Multifunction Protein in Human Diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acr.2018.02.005_bb0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1744-313X.2005.00540.x","article-title":"Alternative splicing of IL-24 in melanocytes by deletion of exons 3 and 5","volume":"32","author":"Allen","year":"2005","journal-title":"International Journal of Immunogenetics"},{"key":"10.1016\/bs.acr.2018.02.005_bb0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.0022-202X.2004.23321.x","article-title":"Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma","volume":"123","author":"Allen","year":"2004","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4049\/jimmunol.0804169","article-title":"Expression of IL-24, an activator of the JAK1\/STAT3\/SOCS3 cascade, is enhanced in inflammatory bowel disease","volume":"183","author":"Andoh","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0025","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/jcp.22947","article-title":"Enhanced delivery of mda-7\/IL-24 using a serotype chimeric adenovirus (Ad.5\/3) in combination with the apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells","volume":"227","author":"Azab","year":"2012","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0030","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1158\/0008-5472.CAN-15-2959","article-title":"mda-7\/IL-24 induces cell death in neuroblastoma through a novel mechanism involving AIF and ATM","volume":"76","author":"Bhoopathi","year":"2016","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0035","first-page":"2726","article-title":"Targeting breast cancer-initiating\/stem cells with melanoma differentiation-associated gene-7\/interleukin-24","volume":"133","author":"Bhutia","year":"2013","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.acr.2018.02.005_bb0040","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/jcp.22904","article-title":"mda-7\/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer","volume":"227","author":"Bhutia","year":"2012","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0045","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1158\/0008-5472.CAN-09-3647","article-title":"Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7\/interleukin-24","volume":"70","author":"Bhutia","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-0-12-407173-5.00003-0","article-title":"Autophagy: Cancer's friend or foe?","volume":"118","author":"Bhutia","year":"2013","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cyto.2011.05.018","article-title":"Myeloid cells migrate in response to IL-24","volume":"55","author":"Buzas","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/bs.acr.2018.02.005_bb0060","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.168.12.6041","article-title":"The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24","volume":"168","author":"Caudell","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0065","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ymthe.2004.12.021","article-title":"mda-7\/IL24 kills pancreatic cancer cells by inhibition of the Wnt\/PI3K signaling pathways: Identification of IL-20 receptor-mediated bystander activity against pancreatic cancer","volume":"11","author":"Chada","year":"2005","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.cgt.7700915","article-title":"mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: Correlation with expression of bcl-2 family members","volume":"13","author":"Chada","year":"2006","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ymthe.2004.08.020","article-title":"Bystander activity of Ad-mda7: Human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism","volume":"10","author":"Chada","year":"2004","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.intimp.2004.01.017","article-title":"MDA-7\/IL-24 is a unique cytokine\u2014Tumor suppressor in the IL-10 family","volume":"4","author":"Chada","year":"2004","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1525-0016(03)00176-X","article-title":"Tumor suppressor MDA-7\/IL-24 selectively inhibits vascular smooth muscle cell growth and migration","volume":"8","author":"Chen","year":"2003","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0165-2478(03)00087-7","article-title":"IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26","volume":"88","author":"Conti","year":"2003","journal-title":"Immunology Letters"},{"key":"10.1016\/bs.acr.2018.02.005_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymthe.2004.09.019","article-title":"Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: A phase I study","volume":"11","author":"Cunningham","year":"2005","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0100","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1073\/pnas.1100769108","article-title":"Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7\/IL-24-mediated toxicity","volume":"108","author":"Dash","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/0008-5472.CAN-13-1062","article-title":"Novel mechanism of MDA-7\/IL-24 cancer-specific apoptosis through SARI induction","volume":"74","author":"Dash","year":"2014","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cytogfr.2010.08.004","article-title":"mda-7\/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity","volume":"21","author":"Dash","year":"2010","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.acr.2018.02.005_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/CMR.0b013e3283382155","article-title":"IL-24 gene transfer sensitizes melanoma cells to erlotinib through modulation of the Apaf-1 and Akt signaling pathways","volume":"21","author":"Deng","year":"2011","journal-title":"Melanoma Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CAD.0b013e32833cfbe1","article-title":"MDA-7\/IL-24 as a cancer therapeutic: From bench to bedside","volume":"21","author":"Dent","year":"2010","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/bs.acr.2018.02.005_bb0125","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.167.7.3545","article-title":"Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types","volume":"167","author":"Dumoutier","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ijc.1437","article-title":"Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas","volume":"94","author":"Ekmekcioglu","year":"2001","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.acr.2018.02.005_bb0135","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1200\/JCO.2002.20.4.1069","article-title":"Loss of MDA-7 expression with progression of melanoma","volume":"20","author":"Ellerhorst","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jcp.20906","article-title":"Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy","volume":"210","author":"Emdad","year":"2007","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4161\/cbt.8.5.7581","article-title":"Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7\/IL-24","volume":"8","author":"Emdad","year":"2009","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0150","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1158\/1535-7163.MCT-07-0399","article-title":"Melanoma differentiation associated gene-7\/interleukin-24 reverses multidrug resistance in human colorectal cancer cells","volume":"6","author":"Emdad","year":"2007","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.acr.2018.02.005_bb0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jcp.20663","article-title":"Ionizing radiation enhances adenoviral vector expressing mda-7\/IL-24-mediated apoptosis in human ovarian cancer","volume":"208","author":"Emdad","year":"2006","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4161\/cbt.10.12.13497","article-title":"Enhancing mda-7\/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5\/3 gene delivery","volume":"10","author":"Eulitt","year":"2010","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0165","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1200\/JCO.2007.15.1829","article-title":"Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis","volume":"26","author":"Eyler","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.tcb.2013.07.006","article-title":"Evading apoptosis in cancer","volume":"23","author":"Fernald","year":"2013","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gene.2008.05.008","article-title":"Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes","volume":"420","author":"Filippov","year":"2008","journal-title":"Gene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0180","doi-asserted-by":"crossref","first-page":"10128","DOI":"10.1158\/0008-5472.CAN-05-3127","article-title":"Is mda-7\/IL-24 a \u201cmagic bullet\u201d for cancer?","volume":"65","author":"Fisher","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0185","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.4161\/cbt.458","article-title":"mda-7\/IL-24, a novel cancer selective apoptosis inducing cytokine gene: From the laboratory into the clinic","volume":"2","author":"Fisher","year":"2003","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.taap.2006.11.021","article-title":"Melanoma differentiation associated gene-7\/interleukin-24 (mda-7\/IL-24): Novel gene therapeutic for metastatic melanoma","volume":"224","author":"Fisher","year":"2007","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cei.12285","article-title":"Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: A cross-sectional study","volume":"177","author":"Fonseca-Camarillo","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0200","doi-asserted-by":"crossref","first-page":"30526","DOI":"10.1074\/jbc.M109.036061","article-title":"Structural mapping of post-translational modifications in human interleukin-24: Role of N-linked glycosylation and disulfide bonds in secretion and activity","volume":"284","author":"Fuson","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.acr.2018.02.005_bb0205","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00262-008-0647-6","article-title":"Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor","volume":"58","author":"Gao","year":"2009","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0210","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1158\/0008-5472.CAN-08-0156","article-title":"Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7\/IL-24","volume":"68","author":"Gao","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0215","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1158\/0008-5472.CAN-04-3758","article-title":"Activation of the Fas-FasL signaling pathway by MDA-7\/IL-24 kills human ovarian cancer cells","volume":"65","author":"Gopalan","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.intimp.2004.01.015","article-title":"Cytokine and tumor cell apoptosis inducing activity of mda-7\/IL-24","volume":"4","author":"Gopalkrishnan","year":"2004","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/mt.2009.252","article-title":"Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach","volume":"18","author":"Greco","year":"2010","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0230","doi-asserted-by":"crossref","first-page":"a009175","DOI":"10.1101\/cshperspect.a009175","article-title":"The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction","volume":"6","author":"Green","year":"2014","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0235","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jcp.21369","article-title":"Targeted combinatorial therapy of non-small cell lung carcinoma using a GST-fusion protein of full-length or truncated MDA-7\/IL-24 with Tarceva","volume":"215","author":"Gupta","year":"2008","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0240","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.pharmthera.2005.11.005","article-title":"mda-7\/IL-24: Multifunctional cancer-specific apoptosis-inducing cytokine","volume":"111","author":"Gupta","year":"2006","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/bs.acr.2018.02.005_bb0245","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1158\/0008-5472.CAN-06-0577","article-title":"BiP\/GRP78 is an intracellular target for MDA-7\/IL-24 induction of cancer-specific apoptosis","volume":"66","author":"Gupta","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0250","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4161\/cbt.26110","article-title":"Combining histone deacetylase inhibitors with MDA-7\/IL-24 enhances killing of renal carcinoma cells","volume":"14","author":"Hamed","year":"2013","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/mol.113.086553","article-title":"Histone deacetylase inhibitors interact with melanoma differentiation associated-7\/interleukin-24 to kill primary human glioblastoma cells","volume":"84","author":"Hamed","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0260","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/mt.2010.29","article-title":"Inhibition of multiple protective signaling pathways and Ad.5\/3 delivery enhances mda-7\/IL-24 therapy of malignant glioma","volume":"18","author":"Hamed","year":"2010","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb9000","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4161\/cbt.9.7.11116","article-title":"OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins","volume":"9","author":"Hamed","year":"2010","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/bs.acr.2018.02.005_bb0270","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/bs.acr.2018.02.005_bb0275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15216540211470","article-title":"The focal adhesion kinase\u2014A regulator of cell migration and invasion","volume":"53","author":"Hauck","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/bs.acr.2018.02.005_bb0280","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4049\/jimmunol.0901829","article-title":"IL-24 transgenic mice: In vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis","volume":"184","author":"He","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0285","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1038\/sj.onc.1204897","article-title":"Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties","volume":"20","author":"Huang","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0290","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3892\/or.2013.2507","article-title":"MDA-7\/IL-24 suppresses tumor adhesion and invasive potential in hepatocellular carcinoma cell lines","volume":"30","author":"Huo","year":"2013","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.acr.2018.02.005_bb0295","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.mt.6300035","article-title":"mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft","volume":"15","author":"Inoue","year":"2007","journal-title":"Molecular Therapy"},{"issue":"3","key":"10.1016\/bs.acr.2018.02.005_bb0300","first-page":"285","article-title":"Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells","volume":"1","author":"Jiang","year":"1993","journal-title":"Molecular and Cellular Differentiation"},{"key":"10.1016\/bs.acr.2018.02.005_bb0305","first-page":"2477","article-title":"Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression","volume":"11","author":"Jiang","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0310","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1073\/pnas.93.17.9160","article-title":"The melanoma differentiation associated gene mda-7 suppresses cancer cell growth","volume":"93","author":"Jiang","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0315","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.taap.2014.08.019","article-title":"Keratinocyte-derived IL-24 plays a role in the positive feedback regulation of epidermal inflammation in response to environmental and endogenous toxic stressors","volume":"280","author":"Jin","year":"2014","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0320","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/bs.acr.2018.02.005_bb0325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cyto.2007.10.004","article-title":"The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy","volume":"41","author":"Kragstrup","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/bs.acr.2018.02.005_bb0330","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tube.2015.06.004","article-title":"Type 2 diabetes\u2014Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines","volume":"95","author":"Kumar","year":"2015","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/bs.acr.2018.02.005_bb0335","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2013.10.009","article-title":"Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice","volume":"39","author":"Kumari","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/bs.acr.2018.02.005_bb0340","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1600-0625.2006.00516.x","article-title":"Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs","volume":"15","author":"Kunz","year":"2006","journal-title":"Experimental Dermatology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0345","first-page":"985","article-title":"mda-7\/IL-24, novel anticancer cytokine: Focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)","volume":"31","author":"Lebedeva","year":"2007","journal-title":"International Journal of Oncology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0350","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1038\/sj.onc.1206891","article-title":"Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7\/IL-24","volume":"22","author":"Lebedeva","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymthe.2004.08.012","article-title":"mda-7\/IL-24: Exploiting cancer's Achilles' heel","volume":"11","author":"Lebedeva","year":"2005","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb9005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.onc.1205116","article-title":"The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells","volume":"21","author":"Lebedeva","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1044-579X(02)00134-7","article-title":"Restoring apoptosis as a strategy for cancer gene therapy: Focus on p53 and mda-7","volume":"13","author":"Lebedeva","year":"2003","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0365","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.onc.1208183","article-title":"Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis","volume":"24","author":"Lebedeva","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0370","first-page":"8138","article-title":"Melanoma differentiation associated gene-7, mda-7\/interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species","volume":"63","author":"Lebedeva","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0375","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1158\/0008-5472.CAN-08-0072","article-title":"Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7\/interleukin-24 and perillyl alcohol","volume":"68","author":"Lebedeva","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0380","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000343242","article-title":"Interleukin-24 suppresses the growth of vascular smooth muscle cells by inhibiting H(2)O(2)-induced reactive oxygen species production","volume":"90","author":"Lee","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0385","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14728222.2011.534461","article-title":"IL-19, IL-20 and IL-24: Potential therapeutic targets for autoimmune diseases","volume":"15","author":"Leng","year":"2011","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/bs.acr.2018.02.005_bb0390","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/SAP.0b013e3181e05039","article-title":"Adenovirus-mediated human interleukin 24 (MDA-7\/IL-24) selectively suppresses proliferation and induces apoptosis in keloid fibroblasts","volume":"66","author":"Liang","year":"2011","journal-title":"Annals of Plastic Surgery"},{"key":"10.1016\/bs.acr.2018.02.005_bb0395","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1023\/A:1011888126865","article-title":"TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103","volume":"18","author":"Lin","year":"2000","journal-title":"Clinical and Experimental Metastasis"},{"key":"10.1016\/bs.acr.2018.02.005_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2016.01.005","article-title":"The evolving, multifaceted roles of autophagy in cancer","volume":"130","author":"Liu","year":"2016","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbrc.2016.05.088","article-title":"Oncolytic vaccine virus harbouring the IL-24 gene suppresses the growth of lung cancer by inducing apoptosis","volume":"476","author":"Lv","year":"2016","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.acr.2018.02.005_bb0410","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1002\/eji.200939678","article-title":"IL-24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells","volume":"39","author":"Ma","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0415","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.micinf.2011.06.012","article-title":"Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection","volume":"13","author":"Ma","year":"2011","journal-title":"Microbes and Infection"},{"key":"10.1016\/bs.acr.2018.02.005_bb0420","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3892\/or.2016.4633","article-title":"Secreted recombinant human IL-24 protein inhibits the proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro and in vivo","volume":"35","author":"Ma","year":"2016","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.acr.2018.02.005_bb0425","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cgt.2013.79","article-title":"Combination of adenoviruses expressing melanoma differentiation-associated gene-7 and chemotherapeutic agents produces enhanced cytotoxicity on esophageal carcinoma","volume":"21","author":"Ma","year":"2014","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molimm.2016.05.010","article-title":"Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancer","volume":"75","author":"Ma","year":"2016","journal-title":"Molecular Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0435","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.3892\/or.2016.4622","article-title":"Mda-7\/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs","volume":"35","author":"Ma","year":"2016","journal-title":"Oncology Reports"},{"key":"10.1016\/bs.acr.2018.02.005_bb0440","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1182\/blood-2009-05-220251","article-title":"Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells","volume":"115","author":"Maarof","year":"2010","journal-title":"Blood"},{"key":"10.1016\/bs.acr.2018.02.005_bb0445","doi-asserted-by":"crossref","first-page":"a007880","DOI":"10.1101\/cshperspect.a007880","article-title":"Frizzled and LRP5\/6 receptors for Wnt\/beta-catenin signaling","volume":"4","author":"MacDonald","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0450","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.surg.2004.05.022","article-title":"Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2\/neu-overexpressing breast cancer cells","volume":"136","author":"McKenzie","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/bs.acr.2018.02.005_bb0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4471-6458-6_6","article-title":"MDA-7\/IL-24: Multifunctional cancer killing cytokine","volume":"818","author":"Menezes","year":"2014","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0460","doi-asserted-by":"crossref","first-page":"36928","DOI":"10.18632\/oncotarget.6047","article-title":"MDA-7\/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer","volume":"6","author":"Menezes","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acr.2018.02.005_bb0465","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1525-0016(03)00170-9","article-title":"MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells","volume":"8","author":"Mhashilkar","year":"2003","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0470","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.cgt.7700954","article-title":"Melanoma differentiation-associated gene-7 (mda-7)\/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model","volume":"13","author":"Miyahara","year":"2006","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0475","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11523-012-0247-4","article-title":"Lung cancer-initiating cells: A novel target for cancer therapy","volume":"8","author":"Morrison","year":"2013","journal-title":"Targeted Oncology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0480","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: New perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunological Reviews"},{"key":"10.1016\/bs.acr.2018.02.005_bb0485","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/jir.2006.26.877","article-title":"Soluble human MDA-7\/IL-24: Characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes","volume":"26","author":"Mumm","year":"2006","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0490","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1515\/jpm.2010.093","article-title":"The expression pattern of two novel cytokines (IL-24 and IL-29) in human fetal membranes","volume":"38","author":"Nace","year":"2010","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1016\/bs.acr.2018.02.005_bb0495","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1101\/gad.10.17.2105","article-title":"The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors","volume":"10","author":"Naik","year":"1996","journal-title":"Genes and Development"},{"key":"10.1016\/bs.acr.2018.02.005_bb0500","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ymthe.2004.03.014","article-title":"Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation","volume":"9","author":"Nishikawa","year":"2004","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0505","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1535-7163.291.4.2","article-title":"Sulindac enhances adenoviral vector expressing mda-7\/IL-24-mediated apoptosis in human lung cancer","volume":"4","author":"Oida","year":"2005","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.acr.2018.02.005_bb0510","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bjc.2014.227","article-title":"BI-69A11 enhances susceptibility of colon cancer cells to mda-7\/IL-24-induced growth inhibition by targeting Akt","volume":"111","author":"Pal","year":"2014","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.acr.2018.02.005_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122439","article-title":"IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1\/CXCR4 signaling axis","volume":"10","author":"Panneerselvam","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.acr.2018.02.005_bb0520","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-2187-8-15","article-title":"Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities","volume":"8","author":"Panneerselvam","year":"2013","journal-title":"Journal of Molecular Signaling"},{"key":"10.1016\/bs.acr.2018.02.005_bb0525","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1158\/1535-7163.MCT-09-0073","article-title":"MDA-7\/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide\/CD95\/PERK-dependent mechanism","volume":"8","author":"Park","year":"2009","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.acr.2018.02.005_bb0530","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4161\/auto.5725","article-title":"PERK-dependent regulation of MDA-7\/IL-24-induced autophagy in primary human glioma cells","volume":"4","author":"Park","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0535","doi-asserted-by":"crossref","first-page":"47517","DOI":"10.1074\/jbc.M205114200","article-title":"Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor\u2013ligand interactions mediate unique biological functions","volume":"277","author":"Parrish-Novak","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.acr.2018.02.005_bb0540","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0545","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.cgt.7700989","article-title":"Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue","volume":"14","author":"Pataer","year":"2007","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0550","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ymthe.2005.01.018","article-title":"Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR","volume":"11","author":"Pataer","year":"2005","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0555","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jir.2011.0040","article-title":"Enhanced apoptosis-inducing function of MDA-7\/IL-24 RGD mutant via the increased adhesion to tumor cells","volume":"32","author":"Pei","year":"2012","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0560","doi-asserted-by":"crossref","first-page":"E869","DOI":"10.3390\/ijms17060869","article-title":"Mechanism of action and applications of interleukin 24 in immunotherapy","volume":"17","author":"Persaud","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.acr.2018.02.005_bb0565","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1600-0625.2010.01077.x","article-title":"IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes","volume":"19","author":"Poindexter","year":"2010","journal-title":"Experimental Dermatology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0570","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/0008-5472.CAN-16-1731","article-title":"mda-7\/IL-24 mediates cancer cell-specific death via regulation of miR-221 and the beclin-1 axis","volume":"77","author":"Pradhan","year":"2017","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0575","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1124\/mol.110.068007","article-title":"Melanoma differentiation associated gene-7\/interleukin-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by endoplasmic reticulum stress","volume":"78","author":"Rahmani","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0580","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ymthe.2004.01.019","article-title":"Ectopic production of MDA-7\/IL-24 inhibits invasion and migration of human lung cancer cells","volume":"9","author":"Ramesh","year":"2004","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0585","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1523-1747.2003.12626.x","article-title":"Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol","volume":"121","author":"Romer","year":"2003","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0590","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.1002620","article-title":"Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression","volume":"186","author":"Sahoo","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0595","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.acr.2018.02.005_bb0600","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/14712598.7.5.577","article-title":"Melanoma differentiation associated gene-7 (mda-7)\/IL-24: A \u2018magic bullet\u2019 for cancer therapy?","volume":"7","author":"Sarkar","year":"2007","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0605","doi-asserted-by":"crossref","first-page":"10712","DOI":"10.18632\/oncotarget.3544","article-title":"Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic","volume":"6","author":"Sarkar","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.acr.2018.02.005_bb0610","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/mol.114.094375","article-title":"Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach","volume":"87","author":"Sarkar","year":"2015","journal-title":"Molecular Pharmacology"},{"issue":"Suppl","key":"10.1016\/bs.acr.2018.02.005_bb0615","first-page":"30","article-title":"mda-7 (IL-24): Signaling and functional roles","author":"Sarkar","year":"2002","journal-title":"BioTechniques"},{"key":"10.1016\/bs.acr.2018.02.005_bb0620","doi-asserted-by":"crossref","first-page":"10054","DOI":"10.1073\/pnas.152327199","article-title":"mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK","volume":"99","author":"Sarkar","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0625","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/cgt.2008.14","article-title":"A cancer terminator virus eradicates both primary and distant human melanomas","volume":"15","author":"Sarkar","year":"2008","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0630","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1073\/pnas.0506837102","article-title":"Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice","volume":"102","author":"Sarkar","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0635","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/sj.onc.1207958","article-title":"Mechanistic aspects of mda-7\/IL-24 cancer cell selectivity analyzed via a bacterial fusion protein","volume":"23","author":"Sauane","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0640","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jcp.10309","article-title":"Mda-7\/IL-24 induces apoptosis of diverse cancer cell lines through JAK\/STAT-independent pathways","volume":"196","author":"Sauane","year":"2003","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0645","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1359-6101(02)00074-6","article-title":"MDA-7\/IL-24: Novel cancer growth suppressing and apoptosis inducing cytokine","volume":"14","author":"Sauane","year":"2003","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.acr.2018.02.005_bb0650","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1158\/0008-5472.CAN-06-1887","article-title":"N-glycosylation of MDA-7\/IL-24 is dispensable for tumor cell-specific apoptosis and \u201cbystander\u201d antitumor activity","volume":"66","author":"Sauane","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0655","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1073\/pnas.0804089105","article-title":"Autocrine regulation of mda-7\/IL-24 mediates cancer-specific apoptosis","volume":"105","author":"Sauane","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0660","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.4049\/jimmunol.166.10.5859","article-title":"Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells","volume":"166","author":"Schaefer","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0665","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12275-016-6383-2","article-title":"MDA7\/IL-24 is an anti-viral factor that inhibits influenza virus replication","volume":"54","author":"Seong","year":"2016","journal-title":"Journal of Microbiology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0670","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2007.03.004","article-title":"Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways","volume":"254","author":"Shanker","year":"2007","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.acr.2018.02.005_bb0675","doi-asserted-by":"crossref","first-page":"21669","DOI":"10.1074\/jbc.M116.737569","article-title":"Melanoma differentiation-associated gene 7\/IL-24 exerts cytotoxic effects by altering the alternative splicing of Bcl-x pre-mRNA via the SRC\/PKC\u03b4 signaling axis","volume":"291","author":"Shapiro","year":"2016","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.acr.2018.02.005_bb0680","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ymthe.2003.11.014","article-title":"The tumor suppressor activity of MDA-7\/IL-24 is mediated by intracellular protein expression in NSCLC cells","volume":"9","author":"Sieger","year":"2004","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0685","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1038\/sj.onc.1208911","article-title":"Unique aspects of mda-7\/IL-24 antitumor bystander activity: Establishing a role for secretion of MDA-7\/IL-24 protein by normal cells","volume":"24","author":"Su","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0690","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1038\/sj.onc.1209271","article-title":"Ionizing radiation enhances therapeutic activity of mda-7\/IL-24: Overcoming radiation- and mda-7\/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2","volume":"25","author":"Su","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0695","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.onc.1206062","article-title":"Melanoma differentiation associated gene-7, mda-7\/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner","volume":"22","author":"Su","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/bs.acr.2018.02.005_bb0700","doi-asserted-by":"crossref","first-page":"14400","DOI":"10.1073\/pnas.95.24.14400","article-title":"The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice","volume":"95","author":"Su","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0705","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.surg.2005.06.032","article-title":"Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells","volume":"138","author":"Suh","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/bs.acr.2018.02.005_bb0710","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.acr.2016.04.003","article-title":"Evolving strategies for therapeutically targeting cancer stem cells","volume":"131","author":"Talukdar","year":"2016","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0715","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood-2011-05-354050","article-title":"AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL\/AF4-positive ALL model mice","volume":"119","author":"Tamai","year":"2012","journal-title":"Blood"},{"key":"10.1016\/bs.acr.2018.02.005_bb0720","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/jir.2012.0055","article-title":"Critical role of lysine 123 in the ubiquitin-mediated degradation of MDA-7\/IL-24","volume":"32","author":"Tian","year":"2012","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0725","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymthe.2004.09.021","article-title":"Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7\/IL24): Biologic outcome in advanced cancer patients","volume":"11","author":"Tong","year":"2005","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0730","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1089\/jir.2013.0081","article-title":"IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: The genetics of atherosclerotic disease Mexican study","volume":"34","author":"Vargas-Alarcon","year":"2014","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0735","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2567.2005.02094.x","article-title":"Interleukin-24 and its receptors","volume":"114","author":"Wang","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0740","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.15252\/embr.201439675","article-title":"Harnessing the apoptotic programs in cancer stem-like cells","volume":"16","author":"Wang","year":"2015","journal-title":"EMBO Reports"},{"key":"10.1016\/bs.acr.2018.02.005_bb0745","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1074\/jbc.M106043200","article-title":"Interleukin 24 (MDA-7\/MOB-5) signals through two heterodimeric receptors, IL-22R1\/IL-20R2 and IL-20R1\/IL-20R2","volume":"277","author":"Wang","year":"2002","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.acr.2018.02.005_bb0750","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3892\/ijmm.2016.2466","article-title":"The IL-24 gene protects human umbilical vein endothelial cells against H(2)O(2)-induced injury and may be useful as a treatment for cardiovascular disease","volume":"37","author":"Wang","year":"2016","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.acr.2018.02.005_bb0755","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/cbr.2006.370","article-title":"Adenovirus-mediated Il-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesis","volume":"22","author":"Wang","year":"2007","journal-title":"Cancer Biotherapy & Radiopharmaceuticals"},{"key":"10.1016\/bs.acr.2018.02.005_bb0760","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3727\/096504010X12767359113929","article-title":"Ad.mda-7 (IL-24) selectively induces apoptosis in hepatocellular carcinoma cell lines, suppresses metastasis, and enhances the effect of doxorubicin on xenograft tumors","volume":"18","author":"Wang","year":"2010","journal-title":"Oncology Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0765","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2015.09.005","article-title":"Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis","volume":"123","author":"Weiss","year":"2015","journal-title":"Antiviral Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0770","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.gene.6364104","article-title":"Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart","volume":"5","author":"Weiss","year":"2004","journal-title":"Genes Immunology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0775","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/S0065-230X(16)30064-1","article-title":"Preface","volume":"132","author":"Welch","year":"2016","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/bs.acr.2018.02.005_bb0780","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cytogfr.2012.08.004","article-title":"Interleukin 24: Mechanisms and therapeutic potential of an anti-cancer gene","volume":"23","author":"Whitaker","year":"2012","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/bs.acr.2018.02.005_bb0785","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cyto.2011.07.020","article-title":"Splice variants of mda-7\/IL-24 differentially affect survival and induce apoptosis in U2OS cells","volume":"56","author":"Whitaker","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/bs.acr.2018.02.005_bb0790","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"87","author":"Wolk","year":"2009","journal-title":"Journal of Molecular Medicine (Berlin)"},{"key":"10.1016\/bs.acr.2018.02.005_bb0795","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/bs.acr.2018.02.005_bb0800","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/aps.2009.16","article-title":"Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7\/IL-24","volume":"30","author":"Wu","year":"2009","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/bs.acr.2018.02.005_bb0805","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11010-010-0397-6","article-title":"Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7\/IL-24","volume":"340","author":"Xiao","year":"2010","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.acr.2018.02.005_bb0810","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00535-012-0623-y","article-title":"Conditionally replicative adenovirus-based mda-7\/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin","volume":"48","author":"Xu","year":"2013","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/bs.acr.2018.02.005_bb0815","first-page":"E6382","article-title":"Wnt\/beta-catenin signaling promotes self-renewal and inhibits the primed state transition in naive human embryonic stem cells","volume":"113","author":"Xu","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.acr.2018.02.005_bb0820","first-page":"623","article-title":"MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity","volume":"2","author":"Yacoub","year":"2003","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.acr.2018.02.005_bb0825","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/cgt.2013.66","article-title":"Heat-shock protein 90 inhibitors synergistically enhance melanoma differentiation-associated gene-7-mediated cell killing of human pancreatic carcinoma","volume":"20","author":"Zhang","year":"2013","journal-title":"Cancer Gene Therapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0830","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00262-006-0175-1","article-title":"Human interleukin 24 (MDA-7\/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10","volume":"56","author":"Zheng","year":"2007","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.acr.2018.02.005_bb0835","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/bs.acr.2018.02.005_bb0840","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.3892\/ol.2017.5990","article-title":"Interleukin-24 inhibits osteosarcoma cell migration and invasion via the JNK\/c-Jun signaling pathways","volume":"13","author":"Zhuo","year":"2017","journal-title":"Oncology Letters"}],"container-title":["Advances in Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X18300149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X18300149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:11:01Z","timestamp":1758741061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X18300149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128151273"],"references-count":169,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2018.02.005","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}